Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126561442 | 12656144 | 2 | F | 20160613 | 20160817 | 20160816 | 20160819 | EXP | CN-009507513-1608CHN007937 | MERCK | 24.00 | YR | M | Y | 73.00000 | KG | 20160819 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126561442 | 12656144 | 1 | PS | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 80 MICROGRAM, UNK | U | U | 4IQG40713 | 103949 | 80 | UG | POWDER FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126561442 | 12656144 | 1 | Chronic hepatitis B |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126561442 | 12656144 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126561442 | 12656144 | Back pain | |
| 126561442 | 12656144 | Headache | |
| 126561442 | 12656144 | Nausea | |
| 126561442 | 12656144 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126561442 | 12656144 | 1 | 20160613 | 20160613 | 0 |